Ricardo López Almaraz
BioCruces Health research Institute(ES)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Sarcoma Diagnosis and Treatment, DNA Repair Mechanisms, Cancer, Hypoxia, and Metabolism, CRISPR and Genetic Engineering
Most-Cited Works
- → Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia(2019)173 cited
- → Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications(2020)140 cited
- → Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)–associated inflammatory diseases(2015)122 cited
- → Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial(2023)95 cited
- → Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial(2023)79 cited
- → Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome‐positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL‐94, ALL‐99 and ALL‐2005(2011)55 cited
- → DUSP5 expression associates with poor prognosis in human neuroblastoma(2018)46 cited
- → Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations(2021)41 cited
- → Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations(2021)41 cited
- → Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies(2019)33 cited